IP & partnerships

Proprietary lipid-delivery technology for formulation development.

BioGntx is developing and evaluating a Nanostructured Lipid Carrier (NLC)-based formulation platform for selected lipophilic and hydrophobic active ingredients, supported by proprietary formulation know-how and published patent documentation.

01. Commercial pathways

From feasibility to future commercial pathways

  1. 01

    Feasibility

  2. 02

    Prototype development

  3. 03

    Co-development / technology transfer

  4. 04

    Future licensing where appropriate

The appropriate pathway depends on the active, application, development results and objectives of the collaboration.

Patent documentation

BioGntx's technology development is supported by proprietary formulation know-how and published international patent application WO 2025/005799 A1.

02. How it works

A clear, step-by-step path from idea to license.

Every engagement starts small, scales only with validated data and ends in a structured commercial route.

Read the full pathway

  1. 01

    Initial screening call

    Understand your ingredient, intended application and the formulation problem you want to solve.

  2. 02

    Feasibility assessment

    Evaluate technical and commercial potential before committing to prototype development.

  3. 03

    Prototype development

    Test real formulations using BioGntx's NLC-based encapsulation at R&D scale.

  4. 04

    Option-to-license

    A time-limited agreement defining scope, territory and commercial terms.

03. Challenge & opportunity

Turning formulation challenges into product solutions.

Many ingredients have strong commercial potential but are difficult to formulate. BioGntx helps companies explore whether encapsulation can turn those challenges into viable product solutions.

Swipe to compare

01 / 04

The challenge

Ingredients don't mix well with water.

The opportunity

More evenly dispersed within the formulation matrix.

02 / 04

The challenge

Active compounds degrade, oxidise or lose effectiveness over time.

The opportunity

Better protected, more stable over time.

03 / 04

The challenge

Taste, smell or texture become difficult to control.

The opportunity

Improved performance and a more consistent user experience.

04 / 04

The challenge

Products are hard to optimise, scale or deliver consistently.

The opportunity

A clear path toward IP licensing and commercial application.

Mesoparticle encapsulation visualisation

Inside the platform

Encapsulation built around the molecules that matter.

04. Licensing

Future licensing opportunities

Licensing may be considered for suitable technologies and applications once sufficient technical validation has been established. Any licensing structure would be defined according to the specific active, application, development status, territory and agreed commercial scope.

Partner with BioGntx.

Have a difficult-to-formulate lipophilic active? Let's explore whether a feasibility project, prototype-development program or technical collaboration could be the right next step.

Start a feasibility discussion